SEC Form 4 · Updated Daily
GRTX
Insider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| NOVARTIS AG | 10%+ Owner | 2,467,961 | 2020-06-19 | S |
| Novartis Bioventures Ltd | 10%+ Owner | 2,467,961 | 2020-06-19 | S |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2020-06-19 | NOVARTIS AG | Open-market sale | 1,001,312 | $8.25 | 2,467,961 |
| 2020-06-19 | Novartis Bioventures Ltd | Open-market sale | 1,001,312 | $8.25 | 2,467,961 |
| 2020-06-18 | NOVARTIS AG | Open-market sale | 900 | $9.04 | 3,469,273 |
| 2020-06-18 | Novartis Bioventures Ltd | Open-market sale | 900 | $9.04 | 3,469,273 |
| 2020-06-17 | NOVARTIS AG | Open-market sale | 4,622 | $9.27 | 3,470,173 |
| 2020-06-17 | Novartis Bioventures Ltd | Open-market sale | 4,622 | $9.27 | 3,470,173 |
| 2020-06-16 | NOVARTIS AG | Open-market sale | 8,600 | $9.30 | 3,474,795 |
| 2020-06-16 | Novartis Bioventures Ltd | Open-market sale | 8,600 | $9.30 | 3,474,795 |
| 2020-06-15 | NOVARTIS AG | Open-market sale | 6,164 | $9.05 | 3,483,395 |
| 2020-06-15 | Novartis Bioventures Ltd | Open-market sale | 6,164 | $9.05 | 3,483,395 |
| 2020-06-12 | NOVARTIS AG | Open-market sale | 1,500 | $9.19 | 3,489,559 |
| 2020-06-12 | Novartis Bioventures Ltd | Open-market sale | 1,500 | $9.19 | 3,489,559 |
| 2020-06-11 | NOVARTIS AG | Open-market sale | 7,200 | $9.21 | 3,491,059 |
| 2020-06-11 | Novartis Bioventures Ltd | Open-market sale | 7,200 | $9.21 | 3,491,059 |
| 2020-06-10 | NOVARTIS AG | Open-market sale | 8,532 | $9.46 | 3,498,259 |
| 2020-06-10 | Novartis Bioventures Ltd | Open-market sale | 8,532 | $9.46 | 3,498,259 |
| 2020-06-09 | NOVARTIS AG | Open-market sale | 7,000 | $9.38 | 3,506,791 |
| 2020-06-09 | Novartis Bioventures Ltd | Open-market sale | 7,000 | $9.38 | 3,506,791 |
| 2020-06-08 | NOVARTIS AG | Open-market sale | 5,659 | $9.66 | 3,513,791 |
| 2020-06-08 | Novartis Bioventures Ltd | Open-market sale | 5,659 | $9.66 | 3,513,791 |
| 2020-06-05 | NOVARTIS AG | Open-market sale | 8,652 | $9.66 | 3,519,450 |
| 2020-06-05 | Novartis Bioventures Ltd | Open-market sale | 8,652 | $9.66 | 3,519,450 |
| 2020-06-04 | NOVARTIS AG | Open-market sale | 4,088 | $9.55 | 3,528,102 |
| 2020-06-04 | Novartis Bioventures Ltd | Open-market sale | 4,088 | $9.55 | 3,528,102 |
| 2020-06-03 | NOVARTIS AG | Open-market sale | 5,208 | $9.78 | 3,532,190 |
| 2020-06-03 | Novartis Bioventures Ltd | Open-market sale | 5,208 | $9.78 | 3,532,190 |
| 2020-06-02 | NOVARTIS AG | Open-market sale | 5,669 | $9.68 | 3,537,398 |
| 2020-06-02 | Novartis Bioventures Ltd | Open-market sale | 5,669 | $9.68 | 3,537,398 |
| 2019-11-12 | NOVARTIS AG | Conversion (derivative) | 451,609 | — | 0 |
| 2019-11-12 | NOVARTIS AG | Conversion (derivative) | 7,200,000 | — | 0 |
| 2019-11-12 | NOVARTIS AG | Conversion (derivative) | 9,000,000 | — | 0 |
| 2019-11-12 | NOVARTIS AG | Open-market buy | 250,000 | $12.00 | 3,543,067 |
| 2019-11-12 | NOVARTIS AG | Conversion | 3,293,067 | — | 3,293,067 |
| 2019-11-12 | Novartis Bioventures Ltd | Conversion (derivative) | 451,609 | — | 0 |
| 2019-11-12 | Novartis Bioventures Ltd | Conversion (derivative) | 7,200,000 | — | 0 |
| 2019-11-12 | Novartis Bioventures Ltd | Conversion (derivative) | 9,000,000 | — | 0 |
| 2019-11-12 | Novartis Bioventures Ltd | Open-market buy | 250,000 | $12.00 | 3,543,067 |
| 2019-11-12 | Novartis Bioventures Ltd | Conversion | 3,293,067 | — | 3,293,067 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.